HomeInsightsStock Comparison

Balaxi Pharmaceuticals Ltd vs Jeena Sikho Lifecare Ltd Stock Comparison

Balaxi Pharmaceuticals Ltd vs Jeena Sikho Lifecare Ltd Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

  • The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 24.59 as of 18 May 15:30 . The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 13.8 on March 2021 to 14.1 on March 2025 . This represents a CAGR of 0.43% over 5 yearsThe P/E Ratio of Jeena Sikho Lifecare Ltd changed from 11.8 on March 2023 to 0 on March 2025 . This represents a CAGR of -100.00% over 3 years The Market Cap of Balaxi Pharmaceuticals Ltd changed from ₹ 524.5 crore on March 2021 to ₹ 352.89 crore on March 2025 . This represents a CAGR of -7.62% over 5 yearsThe Market Cap of Jeena Sikho Lifecare Ltd changed from ₹ 400.11 crore on March 2023 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 3 years The revenue of Balaxi Pharmaceuticals Ltd for the Dec '25 is ₹ 72.64 crore as compare to the Sep '25 revenue of ₹ 57.76 crore. This represent the growth of 25.76% The revenue of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 224.25 crore as compare to the Sep '25 revenue of ₹ 191.29 crore. This represent the growth of 17.23% The ebitda of Balaxi Pharmaceuticals Ltd for the Dec '25 is ₹ 3.19 crore as compare to the Sep '25 ebitda of ₹ 2.75 crore. This represent the growth of 16% The ebitda of Jeena Sikho Lifecare Ltd for the Dec '25 is ₹ 103.29 crore as compare to the Sep '25 ebitda of ₹ 93.47 crore. This represent the growth of 10.51% The net profit of Balaxi Pharmaceuticals Ltd changed from ₹ 6.48 crore to ₹ 0.31 crore over 7 quarters. This represents a CAGR of -82.40% The net profit of Jeena Sikho Lifecare Ltd changed from ₹ 15.73 crore to ₹ 66.6 crore over 7 quarters. This represents a CAGR of 128.11% The Dividend Payout of Balaxi Pharmaceuticals Ltd changed from 3.41 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 yearsThe Dividend Payout of Jeena Sikho Lifecare Ltd changed from 8.19 % on March 2023 to 14.99 % on March 2025 . This represents a CAGR of 22.32% over 3 years .

About Balaxi Pharmaceuticals Ltd

  • Balaxi Pharmaceuticals Limited was initially incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017 and further changed to Balaxi Pharmaceuticals Limited in 2021.
  • Initially, the Company was incorporated with the object of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

About Jeena Sikho Lifecare Ltd

  • Jeena Sikho Lifecare Limited was originally incorporated as a Private Limited Company as 'Jeena Sikho Lifecare Private Limited' dated May 29, 2017 issued by the Registrar of Companies, Delhi.
  • Subsequently, the Company got the status converted into Public Limited Company and the name was changed to 'Jeena Sikho Lifecare Limited' dated July 05, 2021, via fresh Certificate of Incorporation. Jeena Sikho Lifecare Limited is a renowned Ayurvedic healthcare company headquartered in Zirakpur, Punjab.
  • The Company is one of the leading ayurvedic healthcare system providers in India.
  • The Company is selling more than 250 Herbal/ Ayurvedic products.
  • The Company conducts various health checkup camps, yoga sessions to make people aware of their health problems as well.

FAQs for the comparison of Balaxi Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd

Which company has a larger market capitalization, Balaxi Pharmaceuticals Ltd or Jeena Sikho Lifecare Ltd?

Market cap of Balaxi Pharmaceuticals Ltd is 135 Cr while Market cap of Jeena Sikho Lifecare Ltd is 7,839 Cr

What are the key factors driving the stock performance of Balaxi Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd?

The stock performance of Balaxi Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Balaxi Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd?

As of May 18, 2026, the Balaxi Pharmaceuticals Ltd stock price is INR ₹24.59. On the other hand, Jeena Sikho Lifecare Ltd stock price is INR ₹630.7.

How do dividend payouts of Balaxi Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd compare?

To compare the dividend payouts of Balaxi Pharmaceuticals Ltd and Jeena Sikho Lifecare Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions